Compound ID | 536
Class: Macrolide (14-membered macrolide, fluoroketolide)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Effective against Gram positive cocci and H. influenzae, higher activity than telithromycin |
| Description: | Abbanat DR, Ashley G, Foleno B, FU H, Hilliard J, et al. In vitro and in vivo antibacterial activities of 15-methyl-2-fluoro ketolides. 43rd-ICAAC 2003;246 |
| Institute where first reported: | Kosan Biosciences, USA; Johnson & Johnson Pharmaceutical, US A |
| Year first mentioned: | 2003 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |